Merck’s Cancer-Vaccine Trial Results Surpassed Expectations – So, Why Did RBC Downgrade MRK Stock?
Merck’s Cancer-Vaccine Trial Results Surpassed Expectations – So, Why Did RBC Downgrade MRK Stock? Stocktwits
Covered in this story
What has happened since
- Merck & Co. is up 0.0% since this was published.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $RBC yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on RBC Bearings →Summary aggregated from Stocktwits's public RSS feed. The full reporting belongs to Stocktwits — please read it on their site.